IRD Invest March 2022 - Openpay

IRD Invest March 2022 - "Project: 2025"

Watch the replay of Openpay's CEO (Australia & New Zealand) Dion Appel.

March 31st, 2022 by Paul Langley
Read More

IRD Invest March 2022 - Oventus

IRD Invest 31st March 2022 - "Project: 2025"

Watch the replay of Oventus CEO John Cox's presentation.

March 31st, 2022 by Paul Langley
Read More

IRD Invest March 2022 - Pureprofile

IRD Invest 31st March 2022 - "Project: 2025"

Watch the replay of Pureprofile CEO Martin Filz's presentation.

March 31st, 2022 by Paul Langley
Read More

CEO in focus - Pureprofile's Martin Filz

March 24th, 2022 by Paul Langley
Read More

Servatus launches new trial into the effects of live biotherapeutics on insomnia

Servatus launches new trial into the effects of live biotherapeutics on insomnia, we talk to CEO Dr Wayne Finlayson to discuss this exciting initiative.

March 24th, 2022 by Michael Lovesey
Read More

Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer

Kazia (ASX: KZA) CEO Dr James Garner discusses the enrolment of the first patient into their phase II study of paxalisib in combination with a ketogenic diet to treat glioblastoma (brain cancer)

March 23rd, 2022 by Cherie Hartley
Read More

Recent client coverage highlights

March 23rd, 2022 by Paul Langley
Read More

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

March 17th, 2022 by Jane Lowe
Read More

Interview with Ben Fogarty, CEO (UK) XPON

We speak to Ben Fogarty, CEO (UK & Europe) from XPON Technologies Group (see video below) about what the future holds for them and the impact of the upcoming ‘Metaverse’.

March 17th, 2022 by Paul Langley
Read More

A groundbreaking approach to cancer treatment

A number of breakthrough discoveries for Race Oncology's (ASX:RAC) drug Zantrene® over the past 18 months has seen the company evolve its strategy and clinical programs in order to maximise these opportunities. What does the future for Race look like?

March 16th, 2022 by Paul Langley
Read More

Island Pharmaceuticals discuss the Dengue Fever pandemic

Dengue fever is a massive pandemic that continues to spread beyond geographical limits, with 400 million people affected each year. Island Pharmaceuticals (ASX: ILA) is at the forefront of the battle. Here, CEO David Foster talks about the issue:

March 14th, 2022 by Paul Langley
Read More

IR Department celebrates International Women's Day 2022

Today is International Women’s Day #IWD2022 – a day that shines a spotlight on how we can strive for a world that’s more diverse, equitable and inclusive. It’s a day that recognises the achievements of women, and a world where difference is valued and celebrated!

In recognition of the day, we spoke to some of the inspiring women we work with and invited them to share their views on how we can all take action for a gender equal world in order to #BreakTheBias.

You can find out more about International Women’s Day by visiting https://www.internationalwomensday.com

March 8th, 2022 by Cherie Hartley
Read More